The majority of transformed lymphomas have high standardized uptake values (SUVs) on positron emission tomography (PET) scanning similar to diffuse large B-cell lymphoma (DLBCL)

被引:125
作者
Noy, A. [1 ]
Schoeder, H. [6 ]
Goenen, M. [5 ]
Weissler, M. [2 ]
Ertelt, K. [3 ]
Cohler, C. [4 ]
Portlock, C. [1 ]
Hamlin, P. [1 ]
Yeung, H. W. D. [6 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, New York, NY 10065 USA
[2] Weill Cornell Med Ctr, Dept Med, New York, NY USA
[3] Humboldt Univ, Berlin, Germany
[4] Univ Penn, Philadelphia, PA 19104 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Radiol Nucl Med, New York, NY 10065 USA
关键词
(18)fluoro-2-deoxyglucose (FDG); lymphoma; positron emission tomography (PET); standardized uptake value (SUV); transformation; NON-HODGKINS-LYMPHOMA; MALIGNANT-LYMPHOMA; FDG-PET; F-18-FLUORODEOXYGLUCOSE; CLASSIFICATION; DISEASE;
D O I
10.1093/annonc/mdn657
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We previously correlated non-Hodgkin's lymphoma (NHL) histology with (18)fluoro-2-deoxyglucose-positron emission tomography (FDG-PET) intensity: a standardized uptake value (SUV) > 10 predicted aggressive lymphoma with > 80% certainty and an SUV > 13, with > 90% certainty. Patients and methods: To evaluate SUV in transformed lymphoma, we identified all FDG-PET scans for NHL at Memorial Sloan-Kettering Cancer 1999-2007 with (i) biopsy-proven transformation, (ii) no therapy 60 days before PET scan and (iii) FDG-PET scans no more than 60 days before or 90 days after transformation. Results: In 5 of 40 patients, the biopsy site was excised before PET; in two, only marrow was biopsied. In the remaining 33 patients, the SUV of the biopsy site ranged from 3 to 38, mean 14, median 12. Eighteen of 33 biopsies (55%) had an SUV > 10 and 16 (48%) > 13. The highest SUV in a transformed lymphoma PET scan (SUVstudy-max) ranged from 3.2 to 40, mean 15, median 12. Twenty-five of 40 patients (63%) presented with an SUVstudy-max > 10 and 20 (50%) > 13. Conclusions: Like de novo aggressive lymphomas, the majority of transformations have a high SUVstudy-max for a given pretreatment staging study, although many do not have very high values. Transformation should be suspected in indolent lymphoma with high SUVs on FDG-PET. Biopsies should be directed to the site of greatest FDG avidity.
引用
收藏
页码:508 / 512
页数:5
相关论文
共 16 条
[1]  
Buchmann I, 2001, CANCER, V91, P889
[2]   Molecular Imaging of proliferation in malignant lymphoma [J].
Buck, Andreas K. ;
Bommer, Martin ;
Stilgenbauer, Stephan ;
Juweid, Malik ;
Glatting, Gerhard ;
Schirrmeister, Holger ;
Mattfeldt, Torsten ;
Tepsic, Djurdja ;
Bunjes, Donald ;
Mottaghy, Felix M. ;
Krause, Bernd J. ;
Neumaier, Bernd ;
Doehner, Hartmut ;
Moeller, Peter ;
Reske, Sven N. .
CANCER RESEARCH, 2006, 66 (22) :11055-11061
[3]   Detection of lymphoma in bone marrow by whole-body positron emission tomography [J].
Carr, R ;
Barrington, SF ;
Madan, B ;
O'Doherty, MJ ;
Saunders, CAB ;
van der Walt, J ;
Timothy, AR .
BLOOD, 1998, 91 (09) :3340-3346
[4]  
Conover W.J., 2001, PRACTICAL NONPARAMET, V3
[5]   The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma [J].
Gine, E. ;
Montoto, S. ;
Bosch, F. ;
Arenillas, L. ;
Mercadal, S. ;
Villamor, N. ;
Martinez, A. ;
Colomo, L. ;
Campo, E. ;
Montserrat, E. ;
Lopez-Guillermo, A. .
ANNALS OF ONCOLOGY, 2006, 17 (10) :1539-1545
[6]   World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting - Airlie House, Virginia, November 1997 [J].
Harris, NL ;
Jaffe, ES ;
Diebold, J ;
Flandrin, G ;
Muller-Hermelink, HK ;
Vardiman, J ;
Lister, TA ;
Bloomfield, CD .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (12) :3835-3849
[7]   Lymphoma classification - from controversy to consensus: The REAL and WHO Classification of lymphoid neoplasms [J].
Harris, NL ;
Jaffe, ES ;
Diebold, J ;
Flandrin, G ;
Muller-Hermelink, HK ;
Vardiman, J .
ANNALS OF ONCOLOGY, 2000, 11 :3-10
[8]  
Hoh CK, 1997, J NUCL MED, V38, P343
[9]  
Huang SC, 2000, NUCL MED BIOL, V27, P643
[10]   Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging [J].
Jerusalem, G ;
Beguin, Y ;
Fassotte, MF ;
Najjar, F ;
Paulus, P ;
Rigo, P ;
Fillet, G .
BLOOD, 1999, 94 (02) :429-433